# Impact of Consumption of Beta-glucans on the Intestinal Microbiota and Glucose and Lipid Metabolism

> **NCT02041104** · NA · COMPLETED · sponsor: **Mlinotest Zivilska Industrija d.d.** · enrollment: 51 (actual)

## Conditions studied

- Metabolic Syndrome
- Dyslipidemia
- Obesity, Abdominal
- Hyperglycemia
- Hypertension

## Interventions

- **DIETARY_SUPPLEMENT:** Bread with added beta-glucans
- **DIETARY_SUPPLEMENT:** Placebo Comparator: Bread without added beta-glucans

## Key facts

- **NCT ID:** NCT02041104
- **Lead sponsor:** Mlinotest Zivilska Industrija d.d.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2018-04
- **Final completion:** 2018-04
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2019-06-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02041104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02041104, "Impact of Consumption of Beta-glucans on the Intestinal Microbiota and Glucose and Lipid Metabolism". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02041104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*